| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 2.70e-08 | 12 | 56 | 4 | GO:0048407 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.81e-07 | 46 | 56 | 5 | GO:0030020 | |
| GeneOntologyMolecularFunction | protein domain specific binding | STRN3 OSBP DLGAP3 ATXN2 NPTXR CASKIN1 PAWR HCN2 PLSCR1 SNTB1 | 1.41e-04 | 875 | 56 | 10 | GO:0019904 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.82e-04 | 188 | 56 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL3A1 RPLP1 EPB41L4B COL22A1 BSN SNTB1 COL1A1 COL1A2 | 7.73e-04 | 891 | 56 | 9 | GO:0005198 |
| GeneOntologyMolecularFunction | growth factor binding | 9.60e-04 | 156 | 56 | 4 | GO:0019838 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 2.25e-08 | 12 | 56 | 4 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 2.25e-08 | 12 | 56 | 4 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen trimer | 1.28e-07 | 88 | 56 | 6 | GO:0005581 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 2.67e-07 | 21 | 56 | 4 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen type I trimer | 7.05e-06 | 2 | 56 | 2 | GO:0005584 | |
| GeneOntologyCellularComponent | neuronal cell body | 6.58e-05 | 835 | 56 | 10 | GO:0043025 | |
| GeneOntologyCellularComponent | SAGA-type complex | 1.55e-04 | 39 | 56 | 3 | GO:0070461 | |
| GeneOntologyCellularComponent | cell body | 1.59e-04 | 929 | 56 | 10 | GO:0044297 | |
| GeneOntologyCellularComponent | bBAF complex | 3.13e-04 | 10 | 56 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | dendrite | 4.24e-04 | 858 | 56 | 9 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 4.31e-04 | 860 | 56 | 9 | GO:0097447 | |
| GeneOntologyCellularComponent | brahma complex | 6.28e-04 | 14 | 56 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | RSC-type complex | 7.24e-04 | 15 | 56 | 2 | GO:0016586 | |
| GeneOntologyCellularComponent | vesicle coat | 7.73e-04 | 67 | 56 | 3 | GO:0030120 | |
| GeneOntologyCellularComponent | COPII vesicle coat | 8.26e-04 | 16 | 56 | 2 | GO:0030127 | |
| GeneOntologyCellularComponent | transcription factor TFTC complex | 1.05e-03 | 18 | 56 | 2 | GO:0033276 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 1.41e-03 | 1228 | 56 | 10 | GO:0036477 | |
| GeneOntologyCellularComponent | chromatin | FOXD2 KAT2B HOXD4 KLF14 SMARCC2 SMARCD2 PAWR TAF4 TAF5 FOXE3 KLF2 | 1.66e-03 | 1480 | 56 | 11 | GO:0000785 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.93e-03 | 332 | 56 | 5 | GO:0005788 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 2.05e-03 | 94 | 56 | 3 | GO:0000123 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 2.63e-03 | 215 | 56 | 4 | GO:0030662 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.74e-03 | 104 | 56 | 3 | GO:0031248 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.87e-03 | 530 | 56 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | membrane coat | 2.89e-03 | 106 | 56 | 3 | GO:0030117 | |
| GeneOntologyCellularComponent | coated membrane | 2.89e-03 | 106 | 56 | 3 | GO:0048475 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.92e-03 | 30 | 56 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 3.13e-03 | 109 | 56 | 3 | GO:1902493 | |
| GeneOntologyCellularComponent | transferase complex | 3.93e-03 | 963 | 56 | 8 | GO:1990234 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | 4.16e-03 | 972 | 56 | 8 | GO:0140535 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 5.95e-03 | 817 | 56 | 7 | GO:0098978 | |
| GeneOntologyCellularComponent | tight junction | 6.17e-03 | 139 | 56 | 3 | GO:0070160 | |
| GeneOntologyCellularComponent | transcription factor TFIID complex | 7.05e-03 | 47 | 56 | 2 | GO:0005669 | |
| HumanPheno | Arterial rupture | 2.05e-06 | 8 | 18 | 3 | HP:0025019 | |
| HumanPheno | Biconcave flattened vertebrae | 1.18e-05 | 2 | 18 | 2 | HP:0003321 | |
| HumanPheno | Absent ossification of calvaria | 1.18e-05 | 2 | 18 | 2 | HP:0005623 | |
| HumanPheno | Severe generalized osteoporosis | 1.18e-05 | 2 | 18 | 2 | HP:0005897 | |
| HumanPheno | Femoral bowing present at birth, straightening with time | 1.18e-05 | 2 | 18 | 2 | HP:0005005 | |
| HumanPheno | Neonatal short-limb short stature | 1.32e-05 | 14 | 18 | 3 | HP:0008921 | |
| HumanPheno | Aortic dilatation | 1.57e-05 | 168 | 18 | 6 | HP:0001724 | |
| HumanPheno | Aortic aneurysm | 1.57e-05 | 168 | 18 | 6 | HP:0004942 | |
| HumanPheno | Short limb dwarfism | 3.47e-05 | 19 | 18 | 3 | HP:0003505 | |
| HumanPheno | Hypermobility of distal interphalangeal joints | 3.53e-05 | 3 | 18 | 2 | HP:0006201 | |
| HumanPheno | Popcorn calcification | 3.53e-05 | 3 | 18 | 2 | HP:6000871 | |
| HumanPheno | Generalized osteoporosis | 4.07e-05 | 20 | 18 | 3 | HP:0040160 | |
| HumanPheno | Dwarfism | 4.74e-05 | 21 | 18 | 3 | HP:0001516 | |
| HumanPheno | Inguinal hernia | 5.35e-05 | 312 | 18 | 7 | HP:0000023 | |
| HumanPheno | Vascular dilatation | 6.39e-05 | 215 | 18 | 6 | HP:0002617 | |
| HumanPheno | Cervical insufficiency | 7.05e-05 | 4 | 18 | 2 | HP:0030009 | |
| HumanPheno | Bowing of limbs due to multiple fractures | 7.05e-05 | 4 | 18 | 2 | HP:0003023 | |
| HumanPheno | Biconcave vertebral bodies | 8.12e-05 | 25 | 18 | 3 | HP:0004586 | |
| HumanPheno | Aortic root aneurysm | 8.65e-05 | 70 | 18 | 4 | HP:0002616 | |
| HumanPheno | Dermal translucency | 1.03e-04 | 27 | 18 | 3 | HP:0010648 | |
| HumanPheno | Hypermobility of interphalangeal joints | 1.17e-04 | 5 | 18 | 2 | HP:0005620 | |
| HumanPheno | Basilar impression | 1.17e-04 | 5 | 18 | 2 | HP:0005758 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 1.42e-04 | 30 | 18 | 3 | HP:0005743 | |
| HumanPheno | Joint subluxation | 1.57e-04 | 31 | 18 | 3 | HP:0032153 | |
| HumanPheno | Hernia of the abdominal wall | 1.59e-04 | 506 | 18 | 8 | HP:0004299 | |
| HumanPheno | Abdominal wall defect | 1.71e-04 | 511 | 18 | 8 | HP:0010866 | |
| HumanPheno | Thoracoabdominal wall defect | 1.71e-04 | 511 | 18 | 8 | HP:0100656 | |
| HumanPheno | Crumpled long bones | 1.75e-04 | 6 | 18 | 2 | HP:0006367 | |
| HumanPheno | Dilatation of the ascending aorta | 1.77e-04 | 84 | 18 | 4 | HP:0005111 | |
| HumanPheno | Hyperextensible skin | 1.87e-04 | 162 | 18 | 5 | HP:0000974 | |
| HumanPheno | Bell-shaped thorax | 1.89e-04 | 33 | 18 | 3 | HP:0001591 | |
| HumanPheno | Otosclerosis | 2.45e-04 | 7 | 18 | 2 | HP:0000362 | |
| HumanPheno | Molluscoid pseudotumors | 2.45e-04 | 7 | 18 | 2 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 2.45e-04 | 7 | 18 | 2 | HP:0000139 | |
| HumanPheno | Bladder diverticulum | 2.46e-04 | 36 | 18 | 3 | HP:0000015 | |
| HumanPheno | Abnormal aortic morphology | 2.64e-04 | 401 | 18 | 7 | HP:0001679 | |
| HumanPheno | Atrophic scars | 2.67e-04 | 37 | 18 | 3 | HP:0001075 | |
| HumanPheno | Fragile skin | 2.67e-04 | 37 | 18 | 3 | HP:0001030 | |
| HumanPheno | Convex nasal ridge | 2.84e-04 | 95 | 18 | 4 | HP:0000444 | |
| HumanPheno | Bruising susceptibility | 2.91e-04 | 178 | 18 | 5 | HP:0000978 | |
| HumanPheno | Abnormally lax or hyperextensible skin | 2.99e-04 | 179 | 18 | 5 | HP:0008067 | |
| HumanPheno | Decreased skull ossification | 3.13e-04 | 39 | 18 | 3 | HP:0004331 | |
| HumanPheno | Joint hypermobility | 3.14e-04 | 557 | 18 | 8 | HP:0001382 | |
| HumanPheno | Abnormality of the abdominal wall | 3.26e-04 | 560 | 18 | 8 | HP:0004298 | |
| HumanPheno | Genital hernia | 3.26e-04 | 8 | 18 | 2 | HP:0100823 | |
| HumanPheno | Tibial bowing | 3.63e-04 | 41 | 18 | 3 | HP:0002982 | |
| HumanPheno | Scarring | 3.74e-04 | 102 | 18 | 4 | HP:0100699 | |
| HumanPheno | Impairment of activities of daily living | 3.76e-04 | 188 | 18 | 5 | HP:0031058 | |
| HumanPheno | Thoracolumbar scoliosis | 4.19e-04 | 43 | 18 | 3 | HP:0002944 | |
| HumanPheno | Juvenile aseptic necrosis | 4.19e-04 | 43 | 18 | 3 | HP:0100323 | |
| HumanPheno | Soft skin | 4.48e-04 | 44 | 18 | 3 | HP:0000977 | |
| HumanPheno | Abnormal tibia morphology | 4.49e-04 | 107 | 18 | 4 | HP:0002992 | |
| HumanPheno | Hernia | 4.62e-04 | 589 | 18 | 8 | HP:0100790 | |
| HumanPheno | Cigarette-paper scars | 5.22e-04 | 10 | 18 | 2 | HP:0001073 | |
| HumanPheno | Multiple rib fractures | 6.37e-04 | 11 | 18 | 2 | HP:0006640 | |
| HumanPheno | Dilatation of the cerebral artery | 6.94e-04 | 51 | 18 | 3 | HP:0004944 | |
| HumanPheno | Thoracic aortic aneurysm | 7.16e-04 | 121 | 18 | 4 | HP:0012727 | |
| HumanPheno | Finger joint hypermobility | 7.35e-04 | 52 | 18 | 3 | HP:0006094 | |
| HumanPheno | Thin ribs | 7.35e-04 | 52 | 18 | 3 | HP:0000883 | |
| HumanPheno | Mitral valve prolapse | 7.62e-04 | 123 | 18 | 4 | HP:0001634 | |
| HumanPheno | Arterial dissection | 7.62e-04 | 12 | 18 | 2 | HP:0005294 | |
| HumanPheno | Arteriovenous fistula | 7.62e-04 | 12 | 18 | 2 | HP:0004947 | |
| HumanPheno | Abdominal aortic aneurysm | 8.10e-04 | 125 | 18 | 4 | HP:0005112 | |
| HumanPheno | Protrusio acetabuli | 8.99e-04 | 13 | 18 | 2 | HP:0003179 | |
| HumanPheno | Abnormal uterine cervix morphology | 8.99e-04 | 13 | 18 | 2 | HP:0012888 | |
| HumanPheno | Abnormality of hand joint mobility | 9.62e-04 | 57 | 18 | 3 | HP:0006256 | |
| HumanPheno | Recurrent joint dislocation | 1.05e-03 | 14 | 18 | 2 | HP:0031869 | |
| HumanPheno | Soft, doughy skin | 1.05e-03 | 14 | 18 | 2 | HP:0001027 | |
| HumanPheno | Abnormal elasticity of skin | 1.11e-03 | 238 | 18 | 5 | HP:0010647 | |
| HumanPheno | Abnormal aortic morphology | 1.12e-03 | 363 | 18 | 6 | HP:0030963 | |
| HumanPheno | Pes planus | 1.15e-03 | 365 | 18 | 6 | HP:0001763 | |
| HumanPheno | Muscle flaccidity | 1.21e-03 | 15 | 18 | 2 | HP:0010547 | |
| HumanPheno | Aplasia/Hypoplasia of the lens | 1.21e-03 | 15 | 18 | 2 | HP:0008063 | |
| HumanPheno | Retrognathia | 1.33e-03 | 375 | 18 | 6 | HP:0000278 | |
| HumanPheno | Osteoarthritis | 1.41e-03 | 65 | 18 | 3 | HP:0002758 | |
| HumanPheno | Abnormal mitral valve morphology | 1.45e-03 | 146 | 18 | 4 | HP:0031477 | |
| HumanPheno | Abnormal stapes morphology | 1.55e-03 | 17 | 18 | 2 | HP:0008628 | |
| HumanPheno | Short stepped shuffling gait | 1.55e-03 | 17 | 18 | 2 | HP:0007311 | |
| HumanPheno | Platybasia | 1.55e-03 | 17 | 18 | 2 | HP:0002691 | |
| HumanPheno | Premature rupture of membranes | 1.55e-03 | 17 | 18 | 2 | HP:0001788 | |
| HumanPheno | Decreased calvarial ossification | 1.55e-03 | 17 | 18 | 2 | HP:0005474 | |
| HumanPheno | Subcutaneous hemorrhage | 1.59e-03 | 258 | 18 | 5 | HP:0001933 | |
| HumanPheno | Coxa vara | 1.61e-03 | 68 | 18 | 3 | HP:0002812 | |
| HumanPheno | Abnormality of refraction | 1.63e-03 | 709 | 18 | 8 | HP:0000539 | |
| HumanPheno | Small joint hypermobilty | 1.68e-03 | 69 | 18 | 3 | HP:0430046 | |
| HumanPheno | Thoracic hypoplasia | 1.72e-03 | 153 | 18 | 4 | HP:0005257 | |
| HumanPheno | Multiple prenatal fractures | 1.75e-03 | 18 | 18 | 2 | HP:0005855 | |
| HumanPheno | Atypical scarring of skin | 2.05e-03 | 74 | 18 | 3 | HP:0000987 | |
| HumanPheno | Abnormal morphology of the great vessels | 2.09e-03 | 736 | 18 | 8 | HP:0030962 | |
| HumanPheno | Femoral hernia | 2.16e-03 | 20 | 18 | 2 | HP:0100541 | |
| HumanPheno | Shoulder dislocation | 2.16e-03 | 20 | 18 | 2 | HP:0003834 | |
| HumanPheno | Abnormality of the lower urinary tract | COL3A1 ATXN2 RIN2 SMARCC2 CACNA1H SLC1A4 KCNT1 COL1A1 COL1A2 | 2.29e-03 | 937 | 18 | 9 | HP:0010936 |
| MousePheno | abnormal compact bone lamellar structure | 1.20e-04 | 5 | 49 | 2 | MP:0010970 | |
| MousePheno | decreased tendon stiffness | 1.20e-04 | 5 | 49 | 2 | MP:0003098 | |
| MousePheno | hyperactivity | STRN3 ATXN2 NPTXR SOBP C1QL3 CASKIN1 KLF14 PER1 CCDC120 DMWD KCNT1 WNK2 FOXE3 | 1.42e-04 | 1172 | 49 | 13 | MP:0001399 |
| MousePheno | abnormal tendon physiology | 1.79e-04 | 6 | 49 | 2 | MP:0030802 | |
| MousePheno | decreased channel response intensity | 1.79e-04 | 6 | 49 | 2 | MP:0003488 | |
| MousePheno | abnormal tendon stiffness | 1.79e-04 | 6 | 49 | 2 | MP:0003097 | |
| MousePheno | abnormal channel response | 2.05e-04 | 33 | 49 | 3 | MP:0003484 | |
| MousePheno | abnormal channel response intensity | 2.50e-04 | 7 | 49 | 2 | MP:0003486 | |
| MousePheno | abnormal mechanical nociception | 2.66e-04 | 36 | 49 | 3 | MP:0002734 | |
| MousePheno | abnormal aorta tunica media morphology | 3.38e-04 | 39 | 49 | 3 | MP:0009873 | |
| Domain | Fib_collagen_C | 2.35e-08 | 11 | 56 | 4 | IPR000885 | |
| Domain | COLFI | 2.35e-08 | 11 | 56 | 4 | PF01410 | |
| Domain | NC1_FIB | 2.35e-08 | 11 | 56 | 4 | PS51461 | |
| Domain | Fib_collagen_C | 2.35e-08 | 11 | 56 | 4 | PD002078 | |
| Domain | COLFI | 2.35e-08 | 11 | 56 | 4 | SM00038 | |
| Domain | Collagen | 2.01e-07 | 85 | 56 | 6 | IPR008160 | |
| Domain | Collagen | 2.01e-07 | 85 | 56 | 6 | PF01391 | |
| Domain | VWC | 7.93e-05 | 28 | 56 | 3 | PF00093 | |
| Domain | VWFC_1 | 1.70e-04 | 36 | 56 | 3 | PS01208 | |
| Domain | VWC | 2.00e-04 | 38 | 56 | 3 | SM00214 | |
| Domain | VWFC_2 | 2.00e-04 | 38 | 56 | 3 | PS50184 | |
| Domain | VWF_dom | 2.70e-04 | 42 | 56 | 3 | IPR001007 | |
| Domain | LisH | 3.17e-03 | 28 | 56 | 2 | SM00667 | |
| Domain | LisH | 3.17e-03 | 28 | 56 | 2 | IPR006594 | |
| Domain | LISH | 3.17e-03 | 28 | 56 | 2 | PS50896 | |
| Domain | TF_fork_head_CS_2 | 8.40e-03 | 46 | 56 | 2 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 8.75e-03 | 47 | 56 | 2 | IPR018122 | |
| Domain | FH | 9.49e-03 | 49 | 56 | 2 | SM00339 | |
| Domain | FORK_HEAD_1 | 9.49e-03 | 49 | 56 | 2 | PS00657 | |
| Domain | FORK_HEAD_2 | 9.49e-03 | 49 | 56 | 2 | PS00658 | |
| Domain | Fork_head_dom | 9.49e-03 | 49 | 56 | 2 | IPR001766 | |
| Domain | FORK_HEAD_3 | 9.49e-03 | 49 | 56 | 2 | PS50039 | |
| Domain | Forkhead | 9.49e-03 | 49 | 56 | 2 | PF00250 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 6.58e-08 | 41 | 37 | 5 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 9.48e-08 | 44 | 37 | 5 | M27812 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.51e-07 | 19 | 37 | 4 | MM15512 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 5.03e-07 | 61 | 37 | 5 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 8.07e-07 | 67 | 37 | 5 | M26999 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 8.07e-07 | 67 | 37 | 5 | MM15345 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.05e-06 | 30 | 37 | 4 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.05e-06 | 30 | 37 | 4 | MM15517 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.37e-06 | 32 | 37 | 4 | MM14924 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.52e-06 | 76 | 37 | 5 | MM14573 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.84e-06 | 79 | 37 | 5 | M27643 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.52e-06 | 90 | 37 | 5 | M631 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.79e-06 | 41 | 37 | 4 | M27778 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 6.06e-06 | 46 | 37 | 4 | M198 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.61e-06 | 47 | 37 | 4 | MM14925 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 8.48e-06 | 50 | 37 | 4 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.07e-05 | 53 | 37 | 4 | MM14566 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.57e-05 | 19 | 37 | 3 | M27221 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.65e-05 | 59 | 37 | 4 | M27218 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.88e-05 | 61 | 37 | 4 | M27103 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.28e-05 | 64 | 37 | 4 | M26953 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.58e-05 | 66 | 37 | 4 | M18 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 4.05e-05 | 74 | 37 | 4 | M160 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.50e-05 | 76 | 37 | 4 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.50e-05 | 76 | 37 | 4 | MM14867 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 4.66e-05 | 27 | 37 | 3 | M27217 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 5.21e-05 | 28 | 37 | 3 | MM15957 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 5.73e-05 | 532 | 37 | 8 | M27870 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 6.44e-05 | 30 | 37 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 6.44e-05 | 30 | 37 | 3 | MM15812 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 6.67e-05 | 84 | 37 | 4 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.99e-05 | 85 | 37 | 4 | M16441 | |
| Pathway | WP_IL18_SIGNALING | 7.01e-05 | 273 | 37 | 6 | M39818 | |
| Pathway | REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN | 1.40e-04 | 7 | 37 | 2 | M48265 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.61e-04 | 199 | 37 | 5 | M7253 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.78e-04 | 42 | 37 | 3 | M7169 | |
| Pathway | REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 1.86e-04 | 8 | 37 | 2 | M48236 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.18e-04 | 114 | 37 | 4 | MM14571 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 3.00e-04 | 50 | 37 | 3 | M48087 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 4.16e-04 | 135 | 37 | 4 | MM14781 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 4.35e-04 | 12 | 37 | 2 | MM15093 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 4.35e-04 | 12 | 37 | 2 | M27352 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 4.35e-04 | 12 | 37 | 2 | MM15452 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.77e-04 | 140 | 37 | 4 | M587 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.33e-04 | 258 | 37 | 5 | MM14572 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 5.93e-04 | 63 | 37 | 3 | M11187 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 6.89e-04 | 15 | 37 | 2 | M27161 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 6.99e-04 | 418 | 37 | 6 | MM15587 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 7.74e-04 | 69 | 37 | 3 | M48052 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 7.86e-04 | 16 | 37 | 2 | M9450 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 9.99e-04 | 18 | 37 | 2 | M39421 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 9.99e-04 | 18 | 37 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 9.99e-04 | 18 | 37 | 2 | MM14882 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.05e-03 | 300 | 37 | 5 | M610 | |
| Pathway | REACTOME_DISEASES_OF_HEMOSTASIS | 1.11e-03 | 19 | 37 | 2 | M48230 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.24e-03 | 20 | 37 | 2 | MM15061 | |
| Pathway | WP_FOCAL_ADHESION | 1.41e-03 | 187 | 37 | 4 | MM15913 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.49e-03 | 190 | 37 | 4 | M8240 | |
| Pathway | WP_FOCAL_ADHESION | 1.77e-03 | 199 | 37 | 4 | M39402 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.78e-03 | 24 | 37 | 2 | M13404 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 1.94e-03 | 25 | 37 | 2 | M274 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 2.13e-03 | 98 | 37 | 3 | M27152 | |
| Pathway | WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY | 2.43e-03 | 28 | 37 | 2 | M42541 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 2.60e-03 | 29 | 37 | 2 | M48076 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 2.97e-03 | 31 | 37 | 2 | M39522 | |
| Pathway | WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA | 3.36e-03 | 33 | 37 | 2 | M39870 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 3.57e-03 | 34 | 37 | 2 | MM15531 | |
| Pathway | KEGG_BASAL_TRANSCRIPTION_FACTORS | 3.78e-03 | 35 | 37 | 2 | M4864 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 3.78e-03 | 35 | 37 | 2 | M47969 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 3.78e-03 | 35 | 37 | 2 | MM14512 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 3.78e-03 | 35 | 37 | 2 | M773 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 4.21e-03 | 37 | 37 | 2 | M27797 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 4.44e-03 | 38 | 37 | 2 | MM15456 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.44e-03 | 38 | 37 | 2 | MM14969 | |
| Pathway | REACTOME_NGF_STIMULATED_TRANSCRIPTION | 4.67e-03 | 39 | 37 | 2 | M29793 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 4.67e-03 | 39 | 37 | 2 | M10735 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 4.91e-03 | 40 | 37 | 2 | MM14936 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 5.15e-03 | 134 | 37 | 3 | M3574 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 5.40e-03 | 42 | 37 | 2 | M48237 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 5.66e-03 | 43 | 37 | 2 | M39565 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 5.66e-03 | 43 | 37 | 2 | M53 | |
| Pathway | REACTOME_HIV_TRANSCRIPTION_INITIATION | 6.73e-03 | 47 | 37 | 2 | M29568 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PROMOTER_ESCAPE | 7.01e-03 | 48 | 37 | 2 | MM15424 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 7.43e-03 | 153 | 37 | 3 | MM15522 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 7.82e-03 | 302 | 37 | 4 | M39719 | |
| Pubmed | 9.02e-11 | 6 | 56 | 4 | 9101290 | ||
| Pubmed | Loss of ADAMTS19 causes progressive non-syndromic heart valve disease. | 7.55e-10 | 9 | 56 | 4 | 31844321 | |
| Pubmed | 7.55e-10 | 9 | 56 | 4 | 8900172 | ||
| Pubmed | STRN3 DLGAP3 ATXN2 CASKIN1 SIPA1L3 RANBP9 SMARCC2 TAF4 TAF5 BSN HCN2 KCNT1 WNK2 | 3.26e-09 | 963 | 56 | 13 | 28671696 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 23546968 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 34205850 | ||
| Pubmed | Coordinate patterns of expression of type I and III collagens during mouse development. | 3.95e-09 | 3 | 56 | 3 | 8785585 | |
| Pubmed | Differential expression of type I and type III collagen genes during tooth development. | 3.95e-09 | 3 | 56 | 3 | 1879336 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 12200454 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 17662583 | ||
| Pubmed | Distributions of types I, II and III collagen by region in the human supraspinatus tendon. | 3.95e-09 | 3 | 56 | 3 | 24088220 | |
| Pubmed | Mutations in collagen genes: causes of rare and some common diseases in humans. | 3.95e-09 | 3 | 56 | 3 | 2010058 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 8.12e-09 | 15 | 56 | 4 | 9832566 | |
| Pubmed | Localization of types I and III collagen and fibronectin in the developing mouse palatal shelves. | 1.58e-08 | 4 | 56 | 3 | 8984825 | |
| Pubmed | Immunohistochemical characteristics of developing mandibular angle in fetal mice. | 1.58e-08 | 4 | 56 | 3 | 16356873 | |
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 9880238 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 10633870 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 19932771 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 24361166 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 1409674 | ||
| Pubmed | Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. | 1.58e-08 | 4 | 56 | 3 | 2054384 | |
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 8686743 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 16537906 | ||
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 11973338 | ||
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 3.94e-08 | 5 | 56 | 3 | 14758483 | |
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 15365990 | ||
| Pubmed | Extracellular matrix protein expression during mouse detrusor development. | 3.94e-08 | 5 | 56 | 3 | 12592609 | |
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 19790048 | ||
| Pubmed | 6.25e-08 | 24 | 56 | 4 | 25344368 | ||
| Pubmed | 7.43e-08 | 25 | 56 | 4 | 19180518 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 7.88e-08 | 6 | 56 | 3 | 17029294 | |
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 15514164 | ||
| Pubmed | Development and regeneration of the neonatal digit tip in mice. | 7.88e-08 | 6 | 56 | 3 | 18234177 | |
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 17135260 | ||
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 16556917 | ||
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 7.88e-08 | 6 | 56 | 3 | 3571333 | |
| Pubmed | 1.38e-07 | 7 | 56 | 3 | 23273220 | ||
| Pubmed | 1.38e-07 | 7 | 56 | 3 | 10072783 | ||
| Pubmed | 2.20e-07 | 8 | 56 | 3 | 27664939 | ||
| Pubmed | Filamin B mutations cause chondrocyte defects in skeletal development. | 2.20e-07 | 8 | 56 | 3 | 17510210 | |
| Pubmed | Type XIII collagen strongly affects bone formation in transgenic mice. | 2.20e-07 | 8 | 56 | 3 | 16007336 | |
| Pubmed | 2.20e-07 | 8 | 56 | 3 | 26553654 | ||
| Pubmed | 2.20e-07 | 8 | 56 | 3 | 9164858 | ||
| Pubmed | 2.20e-07 | 8 | 56 | 3 | 18816857 | ||
| Pubmed | 3.30e-07 | 9 | 56 | 3 | 31199918 | ||
| Pubmed | 4.71e-07 | 10 | 56 | 3 | 30738849 | ||
| Pubmed | Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. | 4.71e-07 | 10 | 56 | 3 | 15162503 | |
| Pubmed | 4.71e-07 | 10 | 56 | 3 | 14559231 | ||
| Pubmed | Ucma is not necessary for normal development of the mouse skeleton. | 4.71e-07 | 10 | 56 | 3 | 22155508 | |
| Pubmed | 4.71e-07 | 10 | 56 | 3 | 20864640 | ||
| Pubmed | 4.71e-07 | 10 | 56 | 3 | 2446864 | ||
| Pubmed | VEGF stimulates intramembranous bone formation during craniofacial skeletal development. | 4.71e-07 | 10 | 56 | 3 | 26899202 | |
| Pubmed | Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. | 4.71e-07 | 10 | 56 | 3 | 16109715 | |
| Pubmed | Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse. | 4.75e-07 | 39 | 56 | 4 | 21606205 | |
| Pubmed | Hsp and chaperone distribution during endochondral bone development in mouse embryo. | 6.46e-07 | 11 | 56 | 3 | 9880236 | |
| Pubmed | 6.46e-07 | 11 | 56 | 3 | 2745554 | ||
| Pubmed | Binding of proteins to the PDZ domain regulates proteolytic activity of HtrA1 serine protease. | 6.46e-07 | 11 | 56 | 3 | 15101818 | |
| Pubmed | 6.46e-07 | 11 | 56 | 3 | 35988140 | ||
| Pubmed | 6.46e-07 | 11 | 56 | 3 | 24248941 | ||
| Pubmed | The Type 3 Deiodinase Is a Critical Modulator of Thyroid Hormone Sensitivity in the Fetal Brain. | 8.55e-07 | 45 | 56 | 4 | 34248495 | |
| Pubmed | 8.61e-07 | 12 | 56 | 3 | 32002646 | ||
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 1.12e-06 | 13 | 56 | 3 | 11839810 | |
| Pubmed | 1.12e-06 | 13 | 56 | 3 | 31961823 | ||
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 1.12e-06 | 13 | 56 | 3 | 21173153 | |
| Pubmed | 1.12e-06 | 13 | 56 | 3 | 19653325 | ||
| Pubmed | The Mohawk homeobox gene is a critical regulator of tendon differentiation. | 1.12e-06 | 13 | 56 | 3 | 20498044 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZNF628 CASKIN1 SIPA1L3 MEX3D PER1 CACNA1H SYVN1 DMWD TRIB1 WNK2 COL1A1 | 1.27e-06 | 1105 | 56 | 11 | 35748872 |
| Pubmed | 1.31e-06 | 50 | 56 | 4 | 23658023 | ||
| Pubmed | 1.42e-06 | 14 | 56 | 3 | 30459452 | ||
| Pubmed | Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. | 1.42e-06 | 14 | 56 | 3 | 17194222 | |
| Pubmed | Loss of flow responsive Tie1 results in Impaired
Aortic valve remodeling. | 1.42e-06 | 14 | 56 | 3 | 31319059 | |
| Pubmed | 1.42e-06 | 14 | 56 | 3 | 28809397 | ||
| Pubmed | 1.42e-06 | 14 | 56 | 3 | 29593327 | ||
| Pubmed | Role of LTBP4 in alveolarization, angiogenesis, and fibrosis in lungs. | 1.77e-06 | 15 | 56 | 3 | 28684544 | |
| Pubmed | 1.77e-06 | 15 | 56 | 3 | 12601814 | ||
| Pubmed | 1.77e-06 | 15 | 56 | 3 | 38018454 | ||
| Pubmed | Enhanced BMP signaling leads to enlarged nasal cartilage formation in mice. | 2.18e-06 | 16 | 56 | 3 | 37640003 | |
| Pubmed | 2.18e-06 | 16 | 56 | 3 | 17881772 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11358497 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11143996 | ||
| Pubmed | Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. | 2.55e-06 | 2 | 56 | 2 | 16617118 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15211650 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 35915937 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 27636223 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 32335875 | ||
| Pubmed | [Analysis of COL1A1 and COL1A2 gene variants in two fetuses with osteogenesis imperfecta]. | 2.55e-06 | 2 | 56 | 2 | 37368383 | |
| Pubmed | Osteogenesis imperfecta: comparison of molecular defects with bone histological changes. | 2.55e-06 | 2 | 56 | 2 | 7520724 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 8723681 | ||
| Pubmed | Unequal Impact of COL1A1 and COL1A2 Variants on Dentinogenesis Imperfecta. | 2.55e-06 | 2 | 56 | 2 | 36951356 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 17211858 | ||
| Pubmed | Hrd1 participates in the regulation of collagen I synthesis in renal fibrosis. | 2.55e-06 | 2 | 56 | 2 | 24114659 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 5529814 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 9443882 | ||
| Pubmed | Collagen I and collagen III polymorphisms in women with pelvic organ prolapse. | 2.55e-06 | 2 | 56 | 2 | 32692893 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15241796 | ||
| Pubmed | Mutation spectrum of COL1A1 and COL1A2 genes in Indian patients with osteogenesis imperfecta. | 2.55e-06 | 2 | 56 | 2 | 24668929 | |
| Pubmed | Prenatal Cases Reflect the Complexity of the COL1A1/2 Associated Osteogenesis Imperfecta. | 2.55e-06 | 2 | 56 | 2 | 36140746 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 16521042 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 7945553 | ||
| Pubmed | Differential expression of procollagen genes between mid- and late-gestational fetal fibroblasts. | 2.55e-06 | 2 | 56 | 2 | 19560165 | |
| Interaction | PDGFA interactions | 1.57e-06 | 32 | 54 | 4 | int:PDGFA | |
| Interaction | FGF7 interactions | 9.94e-06 | 16 | 54 | 3 | int:FGF7 | |
| Interaction | SPARC interactions | 2.76e-05 | 65 | 54 | 4 | int:SPARC | |
| Interaction | NFIX interactions | 3.14e-05 | 227 | 54 | 6 | int:NFIX | |
| Interaction | TGFBI interactions | 4.01e-05 | 25 | 54 | 3 | int:TGFBI | |
| Interaction | BCAT1 interactions | 4.14e-05 | 72 | 54 | 4 | int:BCAT1 | |
| Interaction | MAG interactions | 6.32e-05 | 29 | 54 | 3 | int:MAG | |
| Interaction | BGN interactions | 7.01e-05 | 30 | 54 | 3 | int:BGN | |
| Interaction | SMAD2 interactions | 7.19e-05 | 385 | 54 | 7 | int:SMAD2 | |
| Interaction | VWF interactions | 8.54e-05 | 32 | 54 | 3 | int:VWF | |
| Interaction | PDGFB interactions | 9.09e-05 | 88 | 54 | 4 | int:PDGFB | |
| Interaction | TOP3B interactions | ZNF628 ATXN2 CASKIN1 SIPA1L3 MEX3D SEC24B PER1 CACNA1H SYVN1 DMWD TRIB1 WNK2 COL1A1 | 1.03e-04 | 1470 | 54 | 13 | int:TOP3B |
| Interaction | TAF13 interactions | 1.44e-04 | 38 | 54 | 3 | int:TAF13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p33 | 2.55e-03 | 61 | 56 | 2 | chr1p33 | |
| Cytoband | 19p13.3 | 3.08e-03 | 237 | 56 | 3 | 19p13.3 | |
| GeneFamily | Collagens | 6.76e-08 | 46 | 42 | 5 | 490 | |
| GeneFamily | Zinc fingers C2H2-type|Kruppel like factors | 7.87e-04 | 18 | 42 | 2 | 624 | |
| GeneFamily | Forkhead boxes | 4.48e-03 | 43 | 42 | 2 | 508 | |
| Coexpression | NABA_COLLAGENS | 3.35e-08 | 43 | 56 | 5 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 3.78e-08 | 44 | 56 | 5 | M3005 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 5.67e-07 | 141 | 56 | 6 | M10381 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 6.95e-07 | 146 | 56 | 6 | MM973 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 9.31e-07 | 35 | 56 | 4 | MM17054 | |
| Coexpression | LEE_LIVER_CANCER_MYC_E2F1_UP | 6.32e-06 | 56 | 56 | 4 | M4420 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.08e-05 | 64 | 56 | 4 | M2572 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 2.51e-05 | 162 | 56 | 5 | M45037 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 3.24e-05 | 29 | 56 | 3 | MM17055 | |
| Coexpression | NAKAMURA_CANCER_MICROENVIRONMENT_UP | 3.24e-05 | 29 | 56 | 3 | M7581 | |
| Coexpression | GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_DN | 6.85e-05 | 200 | 56 | 5 | M6798 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 8.16e-05 | 337 | 56 | 6 | MM16606 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 8.19e-05 | 107 | 56 | 4 | MM947 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 8.63e-05 | 40 | 56 | 3 | M1574 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 8.80e-05 | 109 | 56 | 4 | M2451 | |
| Coexpression | JONES_OVARY_THECA | 1.31e-04 | 46 | 56 | 3 | M48349 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 1.31e-04 | 46 | 56 | 3 | MM670 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 1.34e-04 | 369 | 56 | 6 | MM16610 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.40e-04 | 47 | 56 | 3 | M7585 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 1.49e-04 | 48 | 56 | 3 | M10253 | |
| Coexpression | CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL | 1.49e-04 | 48 | 56 | 3 | M39318 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 1.49e-04 | 48 | 56 | 3 | MM1088 | |
| Coexpression | LIU_VMYB_TARGETS_UP | 1.49e-04 | 125 | 56 | 4 | M1584 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | 1.76e-04 | 954 | 56 | 9 | MM3689 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 2.44e-04 | 11 | 56 | 2 | M47997 | |
| Coexpression | TRAVAGLINI_LUNG_LIPOFIBROBLAST_CELL | 2.71e-04 | 146 | 56 | 4 | M41677 | |
| Coexpression | NABA_CORE_MATRISOME | 2.78e-04 | 270 | 56 | 5 | MM17057 | |
| Coexpression | KIM_GERMINAL_CENTER_T_HELPER_DN | 2.92e-04 | 12 | 56 | 2 | M1408 | |
| Coexpression | NABA_CORE_MATRISOME | 3.02e-04 | 275 | 56 | 5 | M5884 | |
| Coexpression | POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN | 3.04e-04 | 61 | 56 | 3 | M8510 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 3.67e-04 | 65 | 56 | 3 | M39309 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_DN | 4.02e-04 | 67 | 56 | 3 | M13879 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 4.12e-04 | 163 | 56 | 4 | M2769 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 4.38e-04 | 69 | 56 | 3 | M10165 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 4.44e-04 | 856 | 56 | 8 | M4500 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP | 4.50e-04 | 300 | 56 | 5 | M14151 | |
| Coexpression | CHANG_POU5F1_TARGETS_UP | 4.62e-04 | 15 | 56 | 2 | M9138 | |
| Coexpression | GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN | 5.26e-04 | 174 | 56 | 4 | M8931 | |
| Coexpression | DEMAGALHAES_AGING_DN | 5.28e-04 | 16 | 56 | 2 | M2145 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 5.38e-04 | 74 | 56 | 3 | M4479 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 5.38e-04 | 74 | 56 | 3 | M13547 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 5.70e-04 | 316 | 56 | 5 | M2293 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 6.29e-04 | 323 | 56 | 5 | MM1066 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 6.51e-04 | 79 | 56 | 3 | M18400 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 6.71e-04 | 18 | 56 | 2 | MM1241 | |
| Coexpression | KANG_AR_TARGETS_DN | 6.71e-04 | 18 | 56 | 2 | MM892 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 6.71e-04 | 18 | 56 | 2 | M13796 | |
| Coexpression | KANG_AR_TARGETS_DN | 6.71e-04 | 18 | 56 | 2 | M2225 | |
| Coexpression | NAGY_TFTC_COMPONENTS_HUMAN | 6.71e-04 | 18 | 56 | 2 | M2974 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 6.75e-04 | 80 | 56 | 3 | MM1285 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 6.99e-04 | 503 | 56 | 6 | M2226 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 7.00e-04 | 81 | 56 | 3 | M39253 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 7.13e-04 | 505 | 56 | 6 | M39167 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS | 7.26e-04 | 82 | 56 | 3 | M39274 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 7.49e-04 | 19 | 56 | 2 | M15125 | |
| Coexpression | KRAS.DF.V1_DN | 7.76e-04 | 193 | 56 | 4 | M2861 | |
| Coexpression | ZHU_CMV_24_HR_DN | 7.79e-04 | 84 | 56 | 3 | M4065 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 8.22e-04 | 519 | 56 | 6 | M3395 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 8.34e-04 | 86 | 56 | 3 | M2259 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 | 8.67e-04 | 726 | 56 | 7 | M4210 | |
| Coexpression | GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN | 8.70e-04 | 199 | 56 | 4 | M8148 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP | 8.70e-04 | 199 | 56 | 4 | M4607 | |
| Coexpression | GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN | 8.70e-04 | 199 | 56 | 4 | M3517 | |
| Coexpression | GSE3039_CD4_TCELL_VS_NKT_CELL_DN | 8.86e-04 | 200 | 56 | 4 | M6431 | |
| Coexpression | GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_DN | 8.86e-04 | 200 | 56 | 4 | M9385 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN | 8.86e-04 | 200 | 56 | 4 | M6263 | |
| Coexpression | GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP | 8.86e-04 | 200 | 56 | 4 | M7064 | |
| Coexpression | GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN | 8.86e-04 | 200 | 56 | 4 | M4885 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 8.86e-04 | 200 | 56 | 4 | M5930 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_DN | 8.86e-04 | 200 | 56 | 4 | M3729 | |
| Coexpression | GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN | 8.86e-04 | 200 | 56 | 4 | M9067 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN | 8.86e-04 | 200 | 56 | 4 | M9952 | |
| Coexpression | GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN | 8.86e-04 | 200 | 56 | 4 | M9765 | |
| Coexpression | GSE42724_MEMORY_VS_B1_BCELL_UP | 8.86e-04 | 200 | 56 | 4 | M9794 | |
| Coexpression | GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP | 8.86e-04 | 200 | 56 | 4 | M7132 | |
| Coexpression | GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP | 8.86e-04 | 200 | 56 | 4 | M8528 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_DN | 8.86e-04 | 200 | 56 | 4 | M3904 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_UP | 8.86e-04 | 200 | 56 | 4 | M3925 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP | 8.86e-04 | 200 | 56 | 4 | M3850 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C2 | 9.17e-04 | 21 | 56 | 2 | M4767 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 9.25e-04 | 352 | 56 | 5 | M17471 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_DN | 9.36e-04 | 203 | 56 | 4 | M15912 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT | 9.51e-04 | 90 | 56 | 3 | M38984 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 9.61e-04 | 355 | 56 | 5 | M45758 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_SCHWANN_CELLS | 9.82e-04 | 91 | 56 | 3 | M43622 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 9.82e-04 | 91 | 56 | 3 | M40180 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 9.89e-04 | 206 | 56 | 4 | M2817 | |
| Coexpression | DESCARTES_MAIN_FETAL_STROMAL_CELLS | 1.01e-03 | 22 | 56 | 2 | M40074 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 1.02e-03 | 541 | 56 | 6 | MM1061 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.02e-03 | 208 | 56 | 4 | MM581 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 1.04e-03 | 543 | 56 | 6 | MM997 | |
| Coexpression | KAYO_CALORIE_RESTRICTION_MUSCLE_UP | 1.08e-03 | 94 | 56 | 3 | M7013 | |
| Coexpression | DELACROIX_RARG_BOUND_MEF | 1.10e-03 | 366 | 56 | 5 | M2461 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 1.11e-03 | 95 | 56 | 3 | M1111 | |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | 1.18e-03 | 372 | 56 | 5 | M19261 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | 1.19e-03 | 1242 | 56 | 9 | M1920 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 1.19e-03 | 767 | 56 | 7 | M39209 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 | FOXD2 ZNF628 SHC2 ZSWIM5 SIPA1L3 MEX3D CCDC120 SLAIN1 CACNA1H PPP1R14B TRIB1 PLSCR1 WNK2 | 1.36e-05 | 1275 | 54 | 13 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | COL2A1 EPB41L4B NPTXR ZSWIM5 FZD5 KLF14 SLAIN1 CACNA1H TRIB1 WNK2 COL1A1 | 3.12e-05 | 986 | 54 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 3.49e-05 | 498 | 54 | 8 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 1.00e-04 | 95 | 54 | 4 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.09e-04 | 97 | 54 | 4 | GSM777046_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 2.52e-04 | 497 | 54 | 7 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3 | 5.57e-04 | 567 | 54 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3 | |
| CoexpressionAtlas | BM Top 100 - myometrium | 6.07e-04 | 65 | 54 | 3 | BM Top 100 - myometrium | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.35e-04 | 66 | 54 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | BM Top 100 - endometrium | 6.35e-04 | 66 | 54 | 3 | BM Top 100 - endometrium | |
| CoexpressionAtlas | BM Top 100 - cervix | 6.35e-04 | 66 | 54 | 3 | BM Top 100 - cervix | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | COL3A1 EPB41L4B NPTXR KLF14 CCDC120 CACNA1H WNK2 COL1A1 COL1A2 | 6.81e-04 | 967 | 54 | 9 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | 6.81e-04 | 967 | 54 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | BM Top 100 - colon cecum | 6.93e-04 | 68 | 54 | 3 | BM Top 100 - colon cecum | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 7.23e-04 | 69 | 54 | 3 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 7.29e-04 | 281 | 54 | 5 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 7.29e-04 | 281 | 54 | 5 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | BM Top 100 - ovary | 7.54e-04 | 70 | 54 | 3 | BM Top 100 - ovary | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 7.54e-04 | 70 | 54 | 3 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 7.82e-04 | 986 | 54 | 9 | PCBC_EB_fibroblast_1000 | |
| CoexpressionAtlas | BM Top 100 - stomach fundus | 7.86e-04 | 71 | 54 | 3 | BM Top 100 - stomach fundus | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 8.19e-04 | 72 | 54 | 3 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - stomach cardiac | 8.19e-04 | 72 | 54 | 3 | BM Top 100 - stomach cardiac | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | 8.29e-04 | 994 | 54 | 9 | PCBC_ratio_EB_vs_SC_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 8.32e-04 | 607 | 54 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 8.53e-04 | 73 | 54 | 3 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_tips_2500_K1 | COL2A1 ZNF628 SHC2 ZSWIM5 MEX3D SLAIN1 CACNA1H PPP1R14B TRIB1 | 8.65e-04 | 1000 | 54 | 9 | gudmap_RNAseq_e11.5_Ureteric_tips_2500_K1 |
| CoexpressionAtlas | BM Top 100 - mammary gland | 8.87e-04 | 74 | 54 | 3 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 8.87e-04 | 74 | 54 | 3 | BM Top 100 - adipose tissue omental | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-07 | 195 | 56 | 6 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.82e-07 | 198 | 56 | 6 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.82e-07 | 198 | 56 | 6 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-07 | 198 | 56 | 6 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Cd74|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.44e-07 | 115 | 56 | 5 | 4c7d78a246f1b44846fb959359515ef185530053 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.41e-06 | 153 | 56 | 5 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.41e-06 | 153 | 56 | 5 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.41e-06 | 153 | 56 | 5 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.71e-06 | 159 | 56 | 5 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.99e-06 | 164 | 56 | 5 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.05e-06 | 165 | 56 | 5 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.05e-06 | 165 | 56 | 5 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-06 | 165 | 56 | 5 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-06 | 165 | 56 | 5 | 21a82a975f550080b6674750b06212205cd16742 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-06 | 169 | 56 | 5 | 6ff1172da690ca17f7108f1617b255b766971a57 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.66e-06 | 174 | 56 | 5 | 2891ab2fd05eb4bbd239d1a2865f21ef7f2df39e | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.66e-06 | 174 | 56 | 5 | eade55f86ef1f7a5355ad65cec3aa6bfc5d3c62d | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.89e-06 | 177 | 56 | 5 | 599cf7f5b774e197a1b43c98e4b9a8c1a618f38a | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-06 | 178 | 56 | 5 | b902059c3f861108fc64cbdc05e6f44378f5be2c | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.97e-06 | 178 | 56 | 5 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.14e-06 | 180 | 56 | 5 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.31e-06 | 182 | 56 | 5 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 3.40e-06 | 183 | 56 | 5 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.59e-06 | 185 | 56 | 5 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.68e-06 | 186 | 56 | 5 | c0a036096c2cb23305605b8aaf18869d6e0fb512 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.68e-06 | 186 | 56 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.68e-06 | 186 | 56 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 3.88e-06 | 188 | 56 | 5 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.98e-06 | 189 | 56 | 5 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.98e-06 | 189 | 56 | 5 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.09e-06 | 190 | 56 | 5 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.09e-06 | 190 | 56 | 5 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-06 | 190 | 56 | 5 | 591310e615700321a010a4b90405cbbbbdb3aade | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.09e-06 | 190 | 56 | 5 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.19e-06 | 191 | 56 | 5 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.19e-06 | 191 | 56 | 5 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-06 | 192 | 56 | 5 | 8ad6678df89175c5a4a835c8566f1552df3c996e | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class | 4.30e-06 | 192 | 56 | 5 | 0703b8ec6960ff975ee5a2737054db67cab016b5 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-06 | 192 | 56 | 5 | 2f5378ea0b2fb2f672a36585d375f675983363a1 | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 193 | 56 | 5 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 193 | 56 | 5 | 49600db68ed65cafc67bd45a285b364e4f5f88af | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.41e-06 | 193 | 56 | 5 | f27e2be497745098b5269aa799dd3d5f62d78ba7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.41e-06 | 193 | 56 | 5 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.41e-06 | 193 | 56 | 5 | 4ccf984baebbb13ae916727137ce593fda7514a2 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 193 | 56 | 5 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-06 | 194 | 56 | 5 | bbc625b4cc53bb7d6254fde287258e51f9171572 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-06 | 194 | 56 | 5 | fcd5e9238d299c41f0bf9693b56cd8c900d2112b | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-06 | 194 | 56 | 5 | b294056f9bdc243263cf36dce7b62564144b9de1 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-06 | 194 | 56 | 5 | 6afc21c5fec30ab8e373e3e46ab7866204c805b6 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-06 | 195 | 56 | 5 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.75e-06 | 196 | 56 | 5 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 4.75e-06 | 196 | 56 | 5 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-06 | 196 | 56 | 5 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.75e-06 | 196 | 56 | 5 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.75e-06 | 196 | 56 | 5 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.87e-06 | 197 | 56 | 5 | 3fe665c0277d091290b63f0dd24c0c6536a45309 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.00e-06 | 198 | 56 | 5 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Proliferative_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.00e-06 | 198 | 56 | 5 | d9d3520705a1142083782f077a0c5604d3ea99af | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.00e-06 | 198 | 56 | 5 | dc6d9032c5029527e184ac13b887c0c1f22ef1c0 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-06 | 198 | 56 | 5 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.00e-06 | 198 | 56 | 5 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-06 | 198 | 56 | 5 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-06 | 198 | 56 | 5 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-06 | 198 | 56 | 5 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | Parenchyma_COVID-19|World / Sample group, Lineage and Cell type | 5.00e-06 | 198 | 56 | 5 | 45ab554e6d0399b3182f089a25b2adf96de1144b | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.12e-06 | 199 | 56 | 5 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 199 | 56 | 5 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.12e-06 | 199 | 56 | 5 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Proliferative_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.12e-06 | 199 | 56 | 5 | b65fbfed4a9938820cf900afd350b4ecb789b7b3 | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 199 | 56 | 5 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.12e-06 | 199 | 56 | 5 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 5.12e-06 | 199 | 56 | 5 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Proliferative_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.12e-06 | 199 | 56 | 5 | e2d2224e7e9136bcc82d2e460dd7f7ab84b61a96 | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.12e-06 | 199 | 56 | 5 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.12e-06 | 199 | 56 | 5 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 5.25e-06 | 200 | 56 | 5 | eabb7d4aa92ace7d970bcd3fae2c7cb5400a43b4 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.25e-06 | 200 | 56 | 5 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.25e-06 | 200 | 56 | 5 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | 5.25e-06 | 200 | 56 | 5 | ff0b2675c68e9fc1fa16b3276431f199f3642eac | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Mesothelial-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.25e-06 | 200 | 56 | 5 | b33901d91b3af5c0cf310eede30ce03af90c9783 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.25e-06 | 200 | 56 | 5 | 14f3fe19b6647b32a5e28d717235741997d8522c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.25e-06 | 200 | 56 | 5 | 23bc13983f6bdf95e63109b8bc14c4921ca85c3a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuroepithelial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 5.25e-06 | 200 | 56 | 5 | 8b80811a0ec28d1d763c10b095d1969bccbe82d4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 5.25e-06 | 200 | 56 | 5 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuroepithelial-Proteoglycan-expressing_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 5.25e-06 | 200 | 56 | 5 | 52ec80f3922ae6ee3565d5993c2fc56bb3a3199a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.25e-06 | 200 | 56 | 5 | d276062545ecc428a28b12a74f06f3c6bbcff4a3 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.01e-05 | 107 | 56 | 4 | d446ffbe93cd49669f1cf91411aae07cc15d9e2a | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.01e-05 | 107 | 56 | 4 | 5c9e745d0b08a4aa1f3a93f9cc094fac57061a30 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn-Endothelial_Tip.Dcn.Nenf_(Nenf)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.30e-05 | 114 | 56 | 4 | 7be16e7f7b9c9dbd68933ace3b7f8f661bed41a7 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.30e-05 | 114 | 56 | 4 | f4bdfc47418d22a49e0c4a6c3bd0663e15fb53bb | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.31e-05 | 132 | 56 | 4 | 560e836764ed7806fb18282dfebe434d30112a9a | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.31e-05 | 132 | 56 | 4 | 893b7ec2a2d8a140cc98575d1beca1189f053e9a | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.45e-05 | 134 | 56 | 4 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.16e-05 | 143 | 56 | 4 | 4c5a5db46beb8f2f3c40e8ed95911fbfea61bae0 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.25e-05 | 144 | 56 | 4 | e9d62f202f0fa8747961036ef0eafed91fe8a42f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.01e-05 | 152 | 56 | 4 | 3a1414ba6a4972698c3262a00b124428835c35cb | |
| ToppCell | 368C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.01e-05 | 152 | 56 | 4 | ee7855d76a49d07a032677a4dc83aa6116d50518 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.22e-05 | 154 | 56 | 4 | 65dbb60f636562eeba3dafadae9c0c7db2b27476 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.44e-05 | 156 | 56 | 4 | fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.44e-05 | 156 | 56 | 4 | 45a05c7a45a3ec8551818ab67f18b3b9553934c1 | |
| Computational | Neighborhood of CDH11 | 7.54e-05 | 25 | 36 | 3 | GNF2_CDH11 | |
| Computational | Neighborhood of PTX3 | 2.28e-04 | 36 | 36 | 3 | GNF2_PTX3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.07e-04 | 50 | 36 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.07e-04 | 50 | 36 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Drug | Collagenase | 3.28e-11 | 4 | 56 | 4 | DB00048 | |
| Drug | GK-101 | 2.67e-08 | 36 | 56 | 5 | CID000161853 | |
| Drug | ascorbate-2-phosphate | 4.39e-08 | 15 | 56 | 4 | ctd:C011669 | |
| Drug | halofuginone lactate | 6.33e-08 | 85 | 56 | 6 | CID000062891 | |
| Drug | Madecassol | 9.52e-08 | 46 | 56 | 5 | CID000108062 | |
| Drug | d-indobufen | 1.46e-07 | 50 | 56 | 5 | CID000044562 | |
| Drug | ridogrel | 1.78e-07 | 52 | 56 | 5 | CID005362391 | |
| Drug | NSC49633 | 1.97e-07 | 53 | 56 | 5 | CID000023340 | |
| Drug | BPAT-143 | 2.80e-07 | 6 | 56 | 3 | CID000146249 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 2.80e-07 | 6 | 56 | 3 | ctd:C502971 | |
| Drug | PPACK | 3.47e-07 | 113 | 56 | 6 | CID003036757 | |
| Drug | AC1LAKND | 4.36e-07 | 62 | 56 | 5 | CID000470146 | |
| Drug | Selara | 6.29e-07 | 125 | 56 | 6 | CID000150310 | |
| Drug | BAPN | 8.63e-07 | 71 | 56 | 5 | CID000001647 | |
| Drug | malotilate | 8.63e-07 | 71 | 56 | 5 | CID000004006 | |
| Drug | L-3,4-dehydroproline | 9.92e-07 | 73 | 56 | 5 | CID000094284 | |
| Drug | AC1NMZ1B | 1.14e-06 | 75 | 56 | 5 | CID005034185 | |
| Drug | PCR 4099 | 1.17e-06 | 139 | 56 | 6 | CID000002806 | |
| Drug | isodesmosine | 1.27e-06 | 33 | 56 | 4 | CID000013811 | |
| Drug | strontium ranelate | 1.29e-06 | 77 | 56 | 5 | CID006918182 | |
| Drug | N-acetyl-4-benzoquinoneimine | 1.29e-06 | 77 | 56 | 5 | ctd:C028473 | |
| Drug | AC1Q6PCP | 1.49e-06 | 230 | 56 | 7 | CID000005267 | |
| Drug | 4-hydroxyproline | 2.97e-06 | 91 | 56 | 5 | CID000000825 | |
| Drug | ticlopidine | 5.46e-06 | 103 | 56 | 5 | CID000005472 | |
| Drug | 5'-methylthioadenosine | 5.94e-06 | 2 | 56 | 2 | ctd:C008500 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 6.95e-06 | 189 | 56 | 6 | CID000001413 | |
| Drug | foscarnet | 7.16e-06 | 190 | 56 | 6 | CID000003414 | |
| Drug | hydroxylysine | 7.21e-06 | 109 | 56 | 5 | CID000001029 | |
| Drug | AC1L1C2F | 7.54e-06 | 110 | 56 | 5 | CID000001711 | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | 8.07e-06 | 194 | 56 | 6 | 4678_DN | |
| Drug | desmosine | 8.79e-06 | 53 | 56 | 4 | CID000025435 | |
| Drug | AC1L9732 | 8.98e-06 | 114 | 56 | 5 | CID000439300 | |
| Drug | Tranilast sodium | 9.37e-06 | 115 | 56 | 5 | CID000005527 | |
| Drug | 351A | 1.56e-05 | 20 | 56 | 3 | CID000122144 | |
| Drug | DMSe | 1.83e-05 | 132 | 56 | 5 | CID000020796 | |
| Drug | 4-aminoazobenzene | 2.11e-05 | 66 | 56 | 4 | CID000006051 | |
| Drug | pirfenidone | 2.27e-05 | 138 | 56 | 5 | CID000040632 | |
| Drug | DL-penicillamine | 2.35e-05 | 139 | 56 | 5 | CID000004727 | |
| Drug | candesartan cilexetil | 2.88e-05 | 145 | 56 | 5 | CID000002540 | |
| Drug | diacetylrhein | 3.55e-05 | 4 | 56 | 2 | ctd:C025292 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 4.89e-05 | 162 | 56 | 5 | CID000072363 | |
| Drug | Saralasin | 5.91e-05 | 5 | 56 | 2 | ctd:D012504 | |
| Drug | khellin | 6.32e-05 | 171 | 56 | 5 | CID000003828 | |
| Drug | AC1L1DD6 | 7.84e-05 | 179 | 56 | 5 | CID000002299 | |
| Drug | cyanogen-bromide | 7.99e-05 | 34 | 56 | 3 | CID000010476 | |
| Drug | Sirius red | 8.72e-05 | 35 | 56 | 3 | CID005486818 | |
| Drug | Diphosphonates | 8.86e-05 | 6 | 56 | 2 | ctd:D004164 | |
| Drug | AG-H-50319 | 8.86e-05 | 6 | 56 | 2 | CID011819195 | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 8.93e-05 | 184 | 56 | 5 | 5340_UP | |
| Drug | deoxypyridinoline | 9.98e-05 | 98 | 56 | 4 | CID000105071 | |
| Drug | AC1L3XKP | 1.03e-04 | 37 | 56 | 3 | CID000123931 | |
| Drug | pyridinoline | 1.04e-04 | 99 | 56 | 4 | CID000105068 | |
| Drug | Y-27632 | 1.04e-04 | 444 | 56 | 7 | CID000005711 | |
| Drug | SC 19220; Down 200; 10uM; PC3; HT_HG-U133A | 1.09e-04 | 192 | 56 | 5 | 7065_DN | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.09e-04 | 192 | 56 | 5 | 6808_DN | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.12e-04 | 193 | 56 | 5 | 3340_UP | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.12e-04 | 193 | 56 | 5 | 4566_DN | |
| Drug | Tungsten Compounds | 1.12e-04 | 101 | 56 | 4 | ctd:D017973 | |
| Drug | AC1L9N61 | 1.17e-04 | 102 | 56 | 4 | CID000449471 | |
| Drug | Lansoprazole [103577-45-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.17e-04 | 195 | 56 | 5 | 3529_UP | |
| Drug | AC1MRIIV | 1.21e-04 | 39 | 56 | 3 | CID003518584 | |
| Drug | Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 4336_UP | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 3886_DN | |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 5250_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 3300_DN | |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 3484_UP | |
| Drug | Cephapirin sodium salt [24356-60-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 3471_UP | |
| Drug | ammonium perchlorate | 1.24e-04 | 7 | 56 | 2 | ctd:C053506 | |
| Drug | neo-gambogic acid | 1.24e-04 | 7 | 56 | 2 | ctd:C045863 | |
| Drug | Oi-1 | 1.24e-04 | 7 | 56 | 2 | CID000448053 | |
| Drug | losigamone | 1.24e-04 | 7 | 56 | 2 | CID000060572 | |
| Drug | Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.26e-04 | 198 | 56 | 5 | 7357_UP | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 1.26e-04 | 198 | 56 | 5 | 1507_UP | |
| Drug | Rimexolone [49697-38-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.29e-04 | 199 | 56 | 5 | 3516_UP | |
| Drug | Thyroxine (L) [51-48-9]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.29e-04 | 199 | 56 | 5 | 3249_UP | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.32e-04 | 200 | 56 | 5 | 7336_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.32e-04 | 200 | 56 | 5 | 5513_UP | |
| Drug | N-methylmesoporphyrin | 1.51e-04 | 42 | 56 | 3 | CID000444708 | |
| Drug | Mevalonic Acid | 1.62e-04 | 111 | 56 | 4 | ctd:D008798 | |
| Drug | PD123177 | 1.62e-04 | 43 | 56 | 3 | CID000114899 | |
| Drug | HHMD | 1.65e-04 | 8 | 56 | 2 | CID000171068 | |
| Drug | 3,4,5-trihydroxy-N-(4-(thiazol-2-ylsulfamoyl)-phenyl)-benzamide | 1.65e-04 | 8 | 56 | 2 | ctd:C000594958 | |
| Drug | NC-4 | 1.74e-04 | 44 | 56 | 3 | CID006420119 | |
| Drug | Ambroxol | 2.12e-04 | 9 | 56 | 2 | ctd:D000551 | |
| Drug | azelastine | 2.12e-04 | 9 | 56 | 2 | ctd:C020976 | |
| Drug | 4-hydroxymercuribenzoate | 2.12e-04 | 9 | 56 | 2 | ctd:C030601 | |
| Drug | ZD7288 | 2.64e-04 | 10 | 56 | 2 | CID000123983 | |
| Drug | enzacamene | 2.88e-04 | 129 | 56 | 4 | ctd:C038939 | |
| Drug | piperidine | 2.96e-04 | 130 | 56 | 4 | CID000008082 | |
| Drug | AC1L1TXN | 3.20e-04 | 54 | 56 | 3 | CID000060791 | |
| Drug | glycyl-L-leucine | 3.20e-04 | 54 | 56 | 3 | CID000092843 | |
| Drug | enterotoxin C, staphylococcal | 3.22e-04 | 11 | 56 | 2 | ctd:C034959 | |
| Drug | colchine | 3.48e-04 | 383 | 56 | 6 | CID000002833 | |
| Drug | ligustrazine | 3.56e-04 | 56 | 56 | 3 | CID000014296 | |
| Drug | 1h00 | 3.56e-04 | 56 | 56 | 3 | CID000445950 | |
| Drug | prostacyclin sodium salt | 3.71e-04 | 250 | 56 | 5 | CID000000159 | |
| Drug | V2O5 | 3.75e-04 | 57 | 56 | 3 | CID000014814 | |
| Drug | trapidil | 3.75e-04 | 57 | 56 | 3 | CID000005531 | |
| Drug | hyaluronan | 4.68e-04 | 263 | 56 | 5 | CID000024759 | |
| Drug | AC1Q641C | 4.81e-04 | 62 | 56 | 3 | CID000005005 | |
| Disease | Ehlers-Danlos Syndrome | 6.11e-08 | 5 | 55 | 3 | C0013720 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.96e-06 | 53 | 55 | 4 | C4707243 | |
| Disease | osteogenesis imperfecta type 3 (is_implicated_in) | 3.41e-06 | 2 | 55 | 2 | DOID:0110339 (is_implicated_in) | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE | 3.41e-06 | 2 | 55 | 2 | C0268345 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 | 3.41e-06 | 2 | 55 | 2 | C4551623 | |
| Disease | osteogenesis imperfecta type 4 (is_implicated_in) | 3.41e-06 | 2 | 55 | 2 | DOID:0110340 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 2 (is_implicated_in) | 3.41e-06 | 2 | 55 | 2 | DOID:0110341 (is_implicated_in) | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE IV | 3.41e-06 | 2 | 55 | 2 | 166220 | |
| Disease | Osteogenesis imperfecta with normal sclerae, dominant form | 3.41e-06 | 2 | 55 | 2 | cv:C0268363 | |
| Disease | Osteogenesis imperfecta type III | 3.41e-06 | 2 | 55 | 2 | cv:C0268362 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE II | 3.41e-06 | 2 | 55 | 2 | 166210 | |
| Disease | Osteogenesis imperfecta, perinatal lethal | 3.41e-06 | 2 | 55 | 2 | cv:C0268358 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE III | 3.41e-06 | 2 | 55 | 2 | 259420 | |
| Disease | osteogenesis imperfecta (is_implicated_in) | 1.02e-05 | 3 | 55 | 2 | DOID:12347 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 3 (implicated_via_orthology) | 1.02e-05 | 3 | 55 | 2 | DOID:0110339 (implicated_via_orthology) | |
| Disease | OSTEOPOROSIS | 2.04e-05 | 4 | 55 | 2 | 166710 | |
| Disease | Osteogenesis imperfecta, dominant perinatal lethal | 3.40e-05 | 5 | 55 | 2 | C0268358 | |
| Disease | osteogenesis imperfecta (implicated_via_orthology) | 3.40e-05 | 5 | 55 | 2 | DOID:12347 (implicated_via_orthology) | |
| Disease | Lobstein Disease | 3.40e-05 | 5 | 55 | 2 | C0023931 | |
| Disease | Osteoporosis | 5.09e-05 | 6 | 55 | 2 | cv:C0029456 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 5.09e-05 | 6 | 55 | 2 | DOID:13359 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos syndrome | 9.48e-05 | 8 | 55 | 2 | cv:C0013720 | |
| Disease | Fibrosis | 1.13e-04 | 50 | 55 | 3 | C0016059 | |
| Disease | Cirrhosis | 1.13e-04 | 50 | 55 | 3 | C1623038 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 1.22e-04 | 9 | 55 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 1.22e-04 | 9 | 55 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 1.22e-04 | 9 | 55 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 1.52e-04 | 10 | 55 | 2 | C0268363 | |
| Disease | Nephrosclerosis | 1.86e-04 | 11 | 55 | 2 | C0027719 | |
| Disease | Aortic Valve Insufficiency | 1.86e-04 | 11 | 55 | 2 | C0003504 | |
| Disease | Osteogenesis imperfecta type III (disorder) | 1.86e-04 | 11 | 55 | 2 | C0268362 | |
| Disease | intracranial aneurysm (is_implicated_in) | 2.22e-04 | 12 | 55 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 2.22e-04 | 12 | 55 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.46e-04 | 163 | 55 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Osteogenesis Imperfecta | 2.63e-04 | 13 | 55 | 2 | C0029434 | |
| Disease | mental or behavioural disorder | 3.51e-04 | 179 | 55 | 4 | EFO_0000677 | |
| Disease | Oral Submucous Fibrosis | 5.12e-04 | 18 | 55 | 2 | C0029172 | |
| Disease | acetate measurement | 6.34e-04 | 20 | 55 | 2 | EFO_0010112 | |
| Disease | Osteogenesis imperfecta | 7.00e-04 | 21 | 55 | 2 | cv:C0029434 | |
| Disease | Liver Cirrhosis | 9.50e-04 | 103 | 55 | 3 | C0023890 | |
| Disease | Left Ventricular Hypertrophy | 9.96e-04 | 25 | 55 | 2 | C0149721 | |
| Disease | Fibrosis, Liver | 1.00e-03 | 105 | 55 | 3 | C0239946 | |
| Disease | Heart valve disease | 1.08e-03 | 26 | 55 | 2 | C0018824 | |
| Disease | macular telangiectasia type 2 | 1.08e-03 | 26 | 55 | 2 | EFO_1002009 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.10e-03 | 243 | 55 | 4 | EFO_0004612, EFO_0020944 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 1.48e-03 | 120 | 55 | 3 | EFO_0004611, EFO_0004639 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.49e-03 | 264 | 55 | 4 | EFO_0008317, EFO_0020944 | |
| Disease | osteoporosis (is_implicated_in) | 1.53e-03 | 31 | 55 | 2 | DOID:11476 (is_implicated_in) | |
| Disease | Cholestasis, Extrahepatic | 1.63e-03 | 32 | 55 | 2 | C0005398 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.73e-03 | 127 | 55 | 3 | EFO_0008595, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPGPPGAPGLNAAGA | 101 | Q5VWW1 | |
| AGGPAPPARAGEPSG | 21 | Q9P299 | |
| GPGPSSGPGAAPAAD | 271 | A6QL63 | |
| AAASGGGPPSGGAPA | 331 | Q13319 | |
| PPPGPASASGPGAAG | 61 | Q09019 | |
| GETGAAGPPGPAGPA | 636 | P02458 | |
| TGAVGAPGAPGPPGS | 1061 | P02458 | |
| PGLAAGPGPAGGAPT | 106 | Q96S59 | |
| PPGPAPPGGGSSDAA | 36 | Q96IZ0 | |
| GSPQALGGPHGPAPA | 786 | Q8WXD9 | |
| PAAASGAAGGTPPGG | 136 | Q6DN14 | |
| AGAGAGPGALPPQPA | 16 | Q92831 | |
| GGGGAAPGPYPSAAP | 41 | Q99700 | |
| GPGGAPAGAAAPEEP | 16 | Q5JUK3 | |
| PPSAPAGGGQLPAAG | 36 | Q9UPA5 | |
| GGGAGSPPAPLAPSA | 371 | Q96HB5 | |
| AGGPGSSAGPPPPSA | 1001 | O15534 | |
| AGHSGPGPAGFPVPN | 51 | O15162 | |
| PDPGPASPYSGSGNG | 416 | Q86XN8 | |
| GGPAPAAGAAPAGGP | 66 | P05386 | |
| GGSAGPPALPGAPAA | 66 | O95502 | |
| GAGGVAAAGPAPAPP | 61 | P22059 | |
| AAAGPAPAPPTGGSG | 66 | P22059 | |
| PGAAGQAPGAPPGSY | 11 | Q9UBV8 | |
| PFGGSGPGPGSALPA | 61 | P09016 | |
| GPPGAPASGGECPAG | 171 | Q13467 | |
| AGPIGSAGPPGFPGA | 246 | P08123 | |
| AGAGPGPAPGTGTAP | 146 | O95886 | |
| GCAPGAAGGSEGPPP | 336 | Q6V0L0 | |
| GPPGADGIAGAAGPP | 1201 | Q8NFW1 | |
| PSAPAAPGAPAASGG | 151 | Q8TD94 | |
| ESGPAGPAGAPGPAG | 1066 | P02461 | |
| GPAGAPGPAGSRGAP | 1071 | P02461 | |
| PGSPSATPAPGGGAD | 2336 | O95180 | |
| SGAAAPAGPGAGPAP | 26 | O95487 | |
| PAAPGGSVFPAGGGP | 51 | Q9H329 | |
| ASGPAPGPGPAEEAG | 131 | Q9UL51 | |
| AAAARGAAGPGPGPP | 101 | O60548 | |
| APAPASGSGPGPGPA | 336 | O60548 | |
| SGSGPGPGPAGLPAF | 341 | O60548 | |
| APPGAGEGSPGPPFA | 426 | O60548 | |
| GEGSPGPPFAAAAGP | 431 | O60548 | |
| AAPAPAPAAGGPAGV | 311 | O00268 | |
| SGQPGPGAAAAAPAP | 326 | O00268 | |
| GSGSAPEAGPAPGFP | 441 | Q86TM6 | |
| PGPAAPDPPGTGASG | 156 | Q15542 | |
| GGPPASEGAGPAAGP | 41 | Q13033 | |
| HPGAGGAQPPDSPAG | 76 | Q13884 | |
| AGRGEAAPTPAPGPG | 46 | Q13461 | |
| GPEPGGAGTPPGAAA | 141 | Q8ND83 | |
| PVGPGATPAAGSGFP | 1596 | O60292 | |
| APAGSGAPPGSLGPS | 996 | Q8TAQ2 | |
| TAGGAALAAPAPGPG | 6 | Q96C90 | |
| ALAAPAPGPGSGGPG | 11 | Q96C90 | |
| PGGGAVAAALGAPPP | 16 | Q92925 | |
| GATGAAGPPGPTGPA | 326 | P02452 | |
| PGPAGAAGPAGNPGA | 376 | P02452 | |
| AGAPGFPGARGPSGP | 406 | P02452 | |
| SPGADGPAGAPGTPG | 936 | P02452 | |
| GTAGSPGGAPPEAAP | 391 | Q8WYP3 | |
| PPPGAAAPAGSAPGG | 141 | Q9P217 | |
| PPPAAPGAGGGSGSA | 71 | Q96RU8 | |
| ASGGADPQPEPAGPG | 56 | P98077 | |
| AGPAAGPGAPGTAAG | 16 | P43007 | |
| GHCSPPAAGDPGPGA | 696 | A7XYQ1 | |
| PGGAAGSAEAAPPPG | 516 | Q2VWA4 | |
| GAPGAPADAGPEPVG | 106 | Q9Y3S1 | |
| SGPASGPAGLPGAPA | 1006 | Q5EBL2 | |
| ASFPPPFGGPGFGAP | 191 | Q9Y5W3 | |
| GGSEGAGAAPCPPNP | 481 | Q9P206 |